Abstract
Sarcopenia, the progressive and generalized loss of skeletal muscle mass and strength/function associated with aging, increases the risk of a vast array of adverse health outcomes, including falls, morbidity, loss of independence, disability, and mortality. As such, sarcopenia poses a huge socioeconomic burden in developed countries. The development and implementation of effective interventions against sarcopenia are therefore a public health priority. A preliminary, fundamental step in such a process entails the agreement of researchers, healthcare professionals and policy-makers around a unique operational definition of sarcopenia. This will facilitate the framing of a clear clinical entity to be incorporated in standard practice, the understanding of the underlying pathophysiology, and the identification of biological targets for drug development.
Lingua originale | English |
---|---|
pagine (da-a) | 633-638 |
Numero di pagine | 6 |
Rivista | CURRENT PROTEIN & PEPTIDE SCIENCE |
Volume | 19 |
DOI | |
Stato di pubblicazione | Pubblicato - 2018 |
Keywords
- Exercise
- Frailty
- Gait speed
- Muscle mass
- Muscle strength
- Operational definition
- Physical performance
- Protein